Wells Fargo (WFC), Goldman Sachs (GS), Citigroup (C), Bank of America (BAC), and Morgan Stanley (MS) all beat estimates, instilling confidence that the Financials sector earned its 28% performance ...

RBC Capital analyst Matthew Hedberg maintained a Buy rating on Dynatrace (DT – Research Report) on January 20 and set a price target of $65.00.

In a report released today, Kian Abouhossein from J.P. Morgan maintained a Buy rating on Commerzbank (0RLW – Research Report), with a price ...

JPMorgan Chase CEO Jamie Dimon on Wednesday said the U.S. stock market is overvalued and explained why he’s a little more ...

Presentation Operator Greetings, and welcome to the Comerica 4th-Quarter and Fiscal-Year 2024 Financial Review Conference ...

NFJ Investment Group CIO John Mowrey reacts to real estate giant Brookfield defaulting on $161 million mortgage for office properties on 'The Claman Countdown.' Carnivore Trading CEO Dutch Masters and ...

While Biogen has made an opportunistic bid for partner Sage, its top executive seemed to play down the urgency for his ...

"Fixed income is beginning 2025 where it left off 2024, which is to say yields are moving higher," said Daryl Clements, a municipal portfolio manager at AllianceBernstein.

Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies.

Analysts are evaluating the financial impact of the wildfires that have charred hillsides, homes and streets in Los Angeles ...

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...